The purpose of this Funding Opportunity Announcement (FOA) is to stimulate the development of innovative tools and strategies for curing HIV infection.
HIV establishes latent infection in long-lived cells that form a reservoir of virus that persists in infected individuals even after years of
credit:
treatment with highly active antiretroviral therapy (HAART).
Curing HIV infection requires innovative strategies to identify and eliminate these reservoir cells.
The task is especially difficult given the lack of HIV protein expression during latency and the low frequency of latently infected cells during treatment.
Novel approaches are therefore sought to efficiently monitor and specifically target reservoirs of latently infected cells to facilitate the testing of strategies to cure HIV infection in vivo.